WSA maintains guidance despite strong growth – CEO explains why

A stringent focus on prices and costs has helped WS Audiology book a revenue growth of 20% despite global supply issues and increasing inflation, CEO Eric Bernard tells MedWatch.
Eric Bernard, CEO of WS Audiology | Photo: WS Audiology / PR
Eric Bernard, CEO of WS Audiology | Photo: WS Audiology / PR
by andreas lønstrup, translated by daniel pedersen

WS Audiology is well on the way to solidifying the financial year of 2021/2022 as a great one for the hearing aid manufacturer.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading